You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Immune-oncology

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

The Immune Landscape of Epithelial Ovarian Cancer

Recruiting
  • Epithelial Ovarian Cancer
  • Collection of tumor samples, blood and vaginal and rectal swabs
  • Bellinzona, Switzerland
    Oncology Institute of Southern Switzerland
Aug 2, 2023

Inflammatory Arthritis, Immune-related Adverse Event Trial (Adalimumab, Prednisone)

Not yet recruiting
  • Inflammatory Arthritis
  • Immune-related Adverse Event
  • (no location specified)
Sep 13, 2023

Lung Cancer Stage IV Trial in Maastricht (Radiation)

Not yet recruiting
  • Lung Cancer Stage IV
  • Radiation
  • Maastricht, Netherlands
    Maastricht Radiation Oncology (Maastro)
Aug 29, 2023

Colitis Trial in Aalborg, Odense, London (Infliximab, Methylprednisolone, Prednisolone)

Not yet recruiting
  • Colitis
  • Aalborg, Denmark
  • +2 more
Jul 7, 2023

Education, Oncology, Immune Trial in Taipei (Immunotherapy Special Training Course (ISTC), Advanced Oncology Nurse Training

Recruiting
  • Education
  • +2 more
  • Immunotherapy Special Training Course (ISTC)
  • Advanced Oncology Nurse Training Course (AONTC)
  • Taipei, Taiwan
    National Taiwan University
Feb 20, 2023

NSCLC Trial in Rotterdam (Nutritional intervention, Immunotherapy)

Recruiting
  • Non-small Cell Lung Cancer
  • Rotterdam, Netherlands
    Erasmus MC
Jun 5, 2023

Breast Cancer, Hormone Receptor-positive Breast Cancer, Hormone Therapy Trial in Taipei City, Taipei (Palbociclib, Ribociclib,

Recruiting
  • Breast Cancer
  • +2 more
  • Taipei City, Taiwan
  • +1 more
Mar 15, 2023

Oncology Patients to Novel Coronavirus Vaccines (IROC)

Recruiting
  • Cancer
  • COVID-19 Vaccination
  • Carmel, Indiana
  • +1 more
Aug 2, 2022

Breast Cancer, Hematologic Malignancy, Immune Checkpoint Inhibitor-Related Myocarditis Trial in Weston (anonymized data

Recruiting
  • Breast Cancer
  • +4 more
  • anonymized data collection during programmed surveillance clinical follow up
  • Weston, Florida
    Cleveland Clinic Florida
Oct 27, 2022

Metastatic Melanoma, Immune Checkpoints Inhibitors, Gastrointestinal Microbiome (Bacterial and Viral) Trial in Ljubljana (Immune

Recruiting
  • Metastatic Melanoma
  • +3 more
  • Immune checkpoint inhibitor
  • Ljubljana, Slovenia
    Institute of Oncology Ljubljana
May 17, 2023

Immune Thrombocytopenia, Autoimmune Hemolytic Anemia, Evans Syndrome Trial in Graz (potential biomarkers)

Recruiting
  • Immune Thrombocytopenia
  • +3 more
  • potential biomarkers
  • Graz, Styria, Austria
    Pediatric Hematology-Oncology Outpatient Clinic
Sep 8, 2022

Axitinib Dose Reduction and Interruption for Adverse Event

Completed
  • Renal Cell Carcinoma
  • New York, New York
    Pfizer
Sep 15, 2022

Liquid Biopsy to Enable Diagnostics and Monitoring for

Recruiting
  • Lymphoproliferative Disorders
  • Lymphoproliferative Disorder Following Transplantation
  • Liquid biopsy
  • Basel, Switzerland
  • +5 more
Mar 24, 2023

Advanced Solid Tumor, Stereotactic Body Radiotherapy, Immune Checkpoint Inhibitor Trial in Peking (Cadonilimab, Stereotactic

Not yet recruiting
  • Advanced Solid Tumor
  • +4 more
  • Peking, Beijing, China
    Department of radiation oncology, Peking University Third Hospit
Jun 20, 2023

Oncology Trial in Berlin (moderate Whole Body Hyperthermia (mWBH))

Recruiting
  • Oncology
  • moderate Whole Body Hyperthermia (mWBH)
  • Berlin, Germany
    Klinik für Radioonkologie und Strahlentherapie
Apr 6, 2023

Malignancy, Immune System Diseases, Autoimmune Diseases Trial in Chapel Hill (Biospecimen Collection, Medical Chart Review,

Recruiting
  • Malignancy
  • +2 more
  • Biospecimen Collection
  • +2 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Feb 11, 2022

Immune Biomarker Study for Head and Neck Cancer

Recruiting
  • Head and Neck Cancer
  • +4 more
  • Sampling
  • Erlangen, Bavaria, Germany
  • +2 more
Jan 23, 2023

HCC Trial in Hong Kong (Zabadinostat (CXD101) and Geptanolimab, Lenvatinib and Sorafenib)

Not yet recruiting
  • HCC
  • Zabadinostat (CXD101) and Geptanolimab
  • Lenvatinib and Sorafenib
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Prince of Wales Hospital
May 15, 2023

Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Tremelimumab, Yttrium-90 radioembolisation)

Recruiting
  • Hepatocellular Carcinoma
  • Hong Kong, Hong Kong
    Department of Clinical Oncology, Queen Mary Hospital
Apr 10, 2023

Understanding immunE-related toXicities by multifACeT Profiling

Recruiting
  • Oncology
    • Chelsea, London, United Kingdom
      Royal Marsden NHS Foundation Trust
    Apr 21, 2022

    Lung Cancer, Chronic Stress Disorder, Immune Checkpoint Inhibitors Trial in Changsha (Gut microbiota detection, Peripheral

    Recruiting
    • Lung Cancer
    • +2 more
    • Gut microbiota detection
    • Peripheral immune cells signature detaction
    • Changsha, Hunan, China
      Department of Oncology, The Second Xiangya Hospital, Central Sou
    Jul 26, 2022

    Metastatic or Locally Advanced Unresectable Solid Tumors Trial in Canada, Spain, United States (M1774, Drug A (DNA Damage

    Recruiting
    • Metastatic or Locally Advanced Unresectable Solid Tumors
    • Houston, Texas
    • +4 more
    Jul 7, 2022

    Melanoma Trial in Boulogne-Billancourt (venous puncture, tumoral biopsy)

    Recruiting
    • Melanoma
    • venous puncture
    • tumoral biopsy
    • Boulogne-Billancourt, France
      Dermato-oncology department, Ambroise Paré hospital, APHP
    Feb 9, 2022

    Non-cutaneous Squamous Cell Carcinoma of Head and Neck Trial in United States (ALKS 4230, Pembrolizumab)

    Completed
    • Non-cutaneous Squamous Cell Carcinoma of Head and Neck
    • Miami, Florida
    • +5 more
    Nov 10, 2022

    Small Cell Lung Cancer, Immunotherapy Trial in Changsha (chronic psychological stress)

    Recruiting
    • Small Cell Lung Cancer
    • Immunotherapy
    • chronic psychological stress
    • Changsha, Hunan, China
      Department of Oncology, The Second Xiangya Hospital, Central Sou
    Jul 22, 2023